×

RNS Number : 4700H

Character Group PLC

15 November 2018

 

 

The Character Group plc

("Group", "Character" or the "Company")

Designers, developers and international distributors of toys, games and giftware

 

 

CHARACTER TAKES TWO OF THE TOP TWELVE TOYS THIS CHRISTMAS UNVEILED AT DREAMTOYS 2018

 

 

LONDON: Thursday, 15 November 2018: The Board of Character (AIM: symbol: CCT.L) is very pleased to report that its principal trading subsidiary, Character Options Limited ("Character Options") has featured strongly in the prestigious best toys of the year wish list. 

 

Each year, the Toy Retailer Association (TRA) releases its "Dream Toys' dream dozen".  Based on the opinions of large chain retailers, small multiples and independent retailers across the UK, the informative listing is regarded as the most independent and authoritative prediction of the toys that will be the most sought after by children this Christmas. 

 

Within this year's "Dream Toys' dream dozen" released at the TRA's annual event in London yesterday Character Options once again was amongst the nine successful companies who have developed the in-demand toys.  Featuring in the top rankings for Character are the Laser X Twin Pack and Cra-Z-Slimy Creations Super Slime Studio. 

 

The Cra-Z-Slimy Creations Super Slime Studio (retailing at £29.99) has been a key creative play kit of the season and has set the trend for children to create their own slime at home.  For Laser X Twin Pack (retailing at £49.99) this is the second year running that it has made the top twelve toys.

 

Jon Diver, Character's Joint MD commented:

"We have great strength and depth across our brands, so we are all delighted that two of our novel lines have listed in the Dream Toys' dream dozen". Our highly experienced teams are dedicated to developing, marketing and distributing innovative and exciting toys that meet today's high expectations that both our customers and the consumer demand in terms of quality and value."

"We are also particularly proud that Character has listed at least one range each year since the TRA listing inception in 2010".

 

Jerry Healy, Group Marketing Director at Character added:

"The annual Dream Toys' dream dozen event is central in our marketing calendar and is a culmination of months of work in creating awareness for the Character Options toy lines. The two products that made the list are key items in our portfolio, so we were delighted to see them included."

 

"We are all very proud of our achievements – our market leading position in the UK ensures that we remain the partner of choice and this is being reflected in our portfolio as it continues to go from strength to strength and feature so favourably within our customers' marketing offering too."

 

 

In addition to the Dream Toys' list, 72 other toys and games were named as being ones to watch out for as the Christmas season ramps up.  10 of these are supplied by Character Options and include Wrapples from Little Live Pets, the Peppa Pig Mobile Medical Centre, Treasure X and the Batman Stretch toy. 

 

Product ranges can be viewed at www.character-online.co.uk.

 

ENQUIRIES
The Character Group plc Jon Diver, Joint Managing Director Kiran Shah, Joint Managing Director and Group Finance Director Jerry Healy, Group Marketing Director
Office:     +44 (0) 208 329 3377 Mobile:   +44 (0) 7831 802219 (JD) Mobile:  +44 (0) 7956 278522 (KS) Email: [email protected]   FTSE sector:  leisure: FTSE AIM All-share: symbol: CCT.L: Market cap: £106m
Panmure Gordon (Nominated Adviser and Joint Broker) Atholl Tweedie, Investment Banking Charles Leigh-Pemberton, Corporate Broking Tel: +44 (0) 20 7886 2500
Allenby Capital Limited (Joint Broker) Nick Athanas Tel:  +44 (0) 20 3328 5656
Evolution PR (Trade and consumer media) Michele Bates Tel: +44 (0) 01327 227010 Email: [email protected]
TooleyStreet Communications Limited (Investor and media relations) Fiona Tooley Tel:  +44 (0) 7785 703523 Email: [email protected]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAEANFSFDSPFEF

Close

×

RNS Number : 4094H

LightwaveRF PLC

15 November 2018

 

RNS Reach

15 November 2018

LightwaveRF plc

(AIM: LWRF)

 

Distribution agreement with Dixons Carphone

 

 

LightwaveRF plc ("LightwaveRF", "Lightwave" or the "Company"), the leading smart home solutions provider, is pleased to announce a distribution agreement with Dixons Carphone to sell Lightwave products online through its electrical retailer, Currys.

 

Currys online, which targets customers both in the UK and internationally, is now selling Lightwave's Smart Socket, Smart Dimmer and Lighting Starter Kit from the Smart Series product range.

 

Additionally, Lightwave has been participating in a number of electronics trade shows. It most recently exhibited at the ElexShow on 1 and 2 November 2018 and it will also be showing at Lux Live, Europe's largest annual lighting exhibition which is taking place at London's ExCel until today. Furthermore, Lightwave will also be exhibiting at Live North on 22 November 2018 at Aintree Racecourse, Liverpool.

 

Jason Elliott, Chief Executive, commented:

 

"We are delighted to have signed an agreement with another high-profile retailer, adding to our existing partnerships with Apple and John Lewis. Thanks to our marketing and sales initiatives, we continue to make good progress in increasing our brand visibility and product availability. Having a presence at these electrical exhibitions is all about building further awareness through demonstrating the effectiveness of our products to a large audience of consumers and retailers."

 

 

For further information:

 

LightwaveRF plc Jason Elliott, CEO Kevin Edwards, CFO	www.lightwaveRF.com +44 (0) 121 250 3625
Stockdale Securities Limited Tom Griffiths/Edward Thomas	www.stockdalesecurities.com +44 (0) 20 7601 6100
Yellow Jersey PR Charles Goodwin/Katie Bairsto	www.yellowjerseypr.com +44 (0) 7747 788 221

 

 

 

 

 

About LightwaveRF

 

LightwaveRF plc is the UK's only fully integrated home automation company.

 

New customers typically buy a starter pack of Link Plus hub and smart dimmer which has Apple HomeKit compatibility, 2-way communication and built-in energy monitoring. Later adding other easy to install devices from the Lightwave range enables further in-home control, monitoring and automation of lighting, heating and power.

 

Devices may be operated manually, by smartphone or tablet-based apps and also through Google Assistant and Amazon Alexa voice control.

 

Leading tech industry publication 9to5 Mac describes Lightwave as "the best UK HomeKit solution for smart lighting".

                                                         

For further information and "Newsletter sign up", please visit:

www.lightwaverf.com/corporate/

                                                    

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAGGGQUGUPRPPC

Close

×

RNS Number : 2566H

Plant Health Care PLC

14 November 2018

 

 

 

14 November 2018

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Positive Developments with Harpin ab in sugarcane in Brazil

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update on the launch of H2Copla (Harpin ab) in sugarcane in Brazil. 

 

Highlights:

–     H2Copla (Harpin ab) has been applied on some 20,000 hectares (Ha) of sugarcane since 'soft launch' in February 2018

–     Average yield increases in excess of 20% are driving strong demand; early adopters plan to switch entirely to H2Copla for the next season

–     Grower response to the results has been very positive

–     Sales by PHC to Coplacana are expected to reach $0.8m in 2018, pointing to strong growth in 2019

 

As previously announced, Brazil sugarcane, with 10 million Ha planted, is an important target for Plant Health Care.  The Company has been developing Harpin ab for use in this crop since 2016.  Coplacana, a very large co-operative and the leading distributor of inputs for sugarcane, was appointed as distributor to launch Harpin ab under the brand name H2Copla.  Following a 'soft launch' in February 2018, Coplacana has been carrying out extensive demonstration trials of the product; H2Copla has been applied on some 20,000 Ha to date by various growers.

 

Trials conducted on behalf of the Company in 2018 showed that single applications of a low dose (100 g per Ha), significantly increased the yield of sugarcane (10-29%).  Moreover, it is possible that the life of the crop may be extended from five to six years, resulting in a material cost reduction for the grower, especially when sugar prices are low. Grower response to the results has been very positive.

 

Furthermore Usina Açucareira Furlan S/A ('Furlan'), a large sugarcane producer located in the state of São Paulo, carried out field trials in 2018, as part of the soft launch by Coplacana, which delivered an average 23% yield increase from H2Copla applicatons. Furlan now plans to use H2Copla on their entire area next season.

 

Gilmar Rorigues de Morais, Agriculture Department Manager at Furlan, said "We are excited about the yield increases from this year's trials and plan to use H2Copla on all of our 20,000 Ha for the 2019 growing season."

 

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, noted: "Grower reaction to demonstration trials of H2Copla has been very positive.  Growers have already treated some 20,000 Ha of sugarcane with the product.  The indication that just one customer (Furlan) plans to use H2Copla on 20,000 Ha next year, points to significant revenue growth in 2019.  Demand for Harpin ab in Brazil is expected to reach at least $0.8m in 2018."

For further information, please contact:

 

Plant Health Care plc

Chris Richards, Executive Chairman and Interim CEO                     Tel: +1 919 926 1600

Jeff Tweedy, COO

 

Arden Partners plc – Nomad and Broker
John Llewellyn-Lloyd / Dan Gee-Summons                                       Tel: +44 (0) 20 7614 5900

 

IFC Advisory – Financial PR

Graham Herring / Miles Nolan / Zach Cohen                                      Tel: +44 (0) 20 3934 6633

 

 

Company website: www.planthealthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

UPDUOUWRWSAAAAA

Close

×

RNS Number : 9732G

Transense Technologies PLC

12 November 2018

 

Transense Technologies plc

("Transense" or the "Company")

New Translogik iTrack Contract Win in new Territory

 

Transense Technologies plc, the provider of sensor systems for the industrial, mining and transportation markets, is pleased to announce that Translogik, its trading division providing tyre management solutions, has won a contract to supply 24 iTrack II mining tyre monitoring systems including the full suite of Data Analytics for large haul trucks at Southern Copper's Cuajone mine in Peru.

These systems are to be supplied on a subscription model basis. This method allows mining companies to benefit from the productivity gains and overhead savings provided by using the system without any of the associated capital cost while providing Transense with a recurring revenue stream.

Josue Vilchez, General Chief Mine Operation, said: "We have conducted extensive trials over the course of the last 18 months with all of the current market leading systems and we have concluded that iTrack is the best TPMS system in the mining environment available. We are very keen to start operations with iTrack II which will allow us to immediately benefit from the increase in production and health and safety that iTrack provides. The system will initially be installed on our Cat 797F Haul Truck fleet however, we expect iTrack will subsequently be rolled out to our extended fleet in Peru which amounts to a further 100 trucks."

 

Graham Storey, CEO of Transense, said: "This is further validation of the superior qualities of the iTrack system over and above any other system available in the market today. Southern Copper's decision to adopt the entire suite of Data Analytics is an indication of the increasing awareness of the value of the analytical data that our 24/7 Monitoring and Analytics centre in Chile produces which greatly enhances the overall value of the system."

 

For further information, please visit www.transense.co.uk or contact:

 

Transense Technologies plc Graham Storey, Chief Executive	Tel: +44 1869 238 380
finnCap (Nomad and Broker) Ed Frisby, Giles Rolls (Corporate Finance) Tim Redfern (Corporate Broking)	Tel: +44 20 7220 0500

  

Notes to editors:

About iTrack II

The iTrack II Mining system provides fast, accurate, reliable real-time data on the condition of the tyres, combined with live tracking of vehicle location and status. Our 24/7 Control Room monitors the pressures and temperatures live, and this information can, for example, be used to ensure tyres do not exceed critical heat thresholds, detect incorrect load distributions, predict suspension failures, eliminate manual tyre pressure checks and much more. All of these benefits increase health and safety as well as reducing maintenance and downtime, which maximises the hours a truck is working (On-Road Truck Working Hours), which directly correlates to an increase in production.

Existing iTrack users have reported increases in tyre life of up to 30% and fuel savings of up to 3%. Savings of this magnitude provide a rapid return on investment with the iTrack system paying for itself in a matter of months, and where the rental option is chosen the system will pay for itself from day one.

www.trans-logik.com/itrack-2/

 

About Southern Copper

SCC is one of the largest integrated copper producers in the world. They produce copper, molybdenum, zinc, lead, coal and silver. All their mining, smelting and refining facilities are located in Peru and Mexico and they conduct exploration activities in those countries and Chile. Since 1996, their common stock is listed on both the New York and Lima Stock Exchanges.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTBCBDBUDGBGIC

Close

×

RNS Number : 8351G

Solid State PLC

09 November 2018

 

 

Solid State plc

("Solid State", the "Company" or the "Group")

Acquisition of Optoelectronics & Displays specialist –

Pacer Technologies Limited

 

Solid State plc (AIM: SOLI), the AIM listed manufacturer of computing, power and communications products, and value added distributor of electronic components, is pleased to announce the acquisition of Pacer Technologies Limited and its subsidiaries ("Pacer") (the "Acquisition").

 

The Company has exchanged contracts to acquire the entire share capital of Pacer Technologies Limited for a cash consideration of £3.73m, subject to a net asset adjustment.  The consideration is being settled out of the Group's existing resources and new banking facilities provided by Lloyds Bank plc.

 

Highlights of the Acquisition include:

 

·      Pacer is well established in the specialist markets of Optoelectronics and Displays

·      The Acquisition significantly enhances Solid State's exposure to the niche Medical sector

·      Pacer focuses on value added component distribution and custom design, targeting enhanced margin opportunities

·      The Acquisition will enable the enlarged Group to further design and manufacture own brand products for distribution utilising Pacer's recent investment in a new value added production facility in Weymouth

·      Pacer has an established US subsidiary

·      Pacer generates circa 40% of its revenues from overseas

·      Consideration is being satisfied out of Group resources and a new term loan facility

·      The Acquisition is expected to be earnings enhancing in the first full year

·      Pacer operates at higher gross margins than the Group's traditional distribution business

·      Pacer will form part of the Group's Distribution division, operating as a separate company

·      The Acquisition gives the Group greater scale, strength and depth in high growth markets

 

For the year ended 31 March 2018, Pacer reported revenue of £15.2m, and a profit before tax of £431k. As at 31 March 2018 Pacer had net assets of £1.06m and had net debt of £1.5m.

 

Introduction to Pacer Technologies Limited:

 

Pacer was established in 1989 to specialise in the distribution and custom design of optoelectronic components, lasers and displays to the OEM market in the medical, military, commercial, industrial and security sectors.  Serving an international client base, Pacer has a reputation for supplying high quality components in a customer-centric manner, often involving custom design and manufacturing to address individual needs.

 

Pacer operates in two areas, Components and Displays, supplying world class blue chip companies.  The Components business is distribution based with a smaller proportion of its sales derived from manufacturing, own brand and assembly based products. Products include industrial LEDs and light sources, lasers and laser range finders, photon detection and counting equipment. The Displays business complements and enhances that of Solid State Supplies. Products include industrial and commercial grade displays.

 

In the UK, Pacer operates from offices in Pangbourne and Weymouth, with a sales office in Crawley. Its US subsidiary is based in Florida.

 

Banking:

 

In completing this deal, the Group's primary banker Lloyds Bank plc has put in place committed facilities made up of £6.0m of term loans and a £3.5m revolving credit facility to fund the consideration and the working capital requirements of the enlarged Group.

These facilities have enabled the Group to refinance Pacer's £3.5m invoice discounting and term loan facilities on better terms. Pacer net debt at 31 March 2018 was £1.5m. Principally due to the capital investment undertaken by Pacer since that date, net debt is expected to be higher than this on completion of the Acquisition.

 

Commenting on the Acquisition, Gary Marsh, Chief Executive of Solid State, said:

 

"Pacer is a company that we have known and admired for many years.  Their expertise and product set are complementary to the existing Solid State Group, with the added benefit of enhancing the value added operations and increasing exposure to high growth markets such as the medical sector. In addition, Pacer has an established US business which provides the Group with an opportunity to further develop its US activities.

 

"The two businesses share many cultural similarities, including the specialist sales force approach, which means that client design teams are talking to like-minded engineers.

 

"We look forward to welcoming the Pacer team to Solid State where we believe they will further grow as part of the enlarged Group."

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information please contact:

 

Solid State plc	01527 830 630
Gary Marsh – Chief Executive Peter James – Group Finance Director	[email protected]
WH Ireland (Nominated Adviser & Joint Broker)	0117 945 3470
Mike Coe / Chris Savidge (Corporate Finance) Jasper Berry / David Kilbourn (Corporate Broking / Sales)
finnCap (Joint Broker) Ed Frisby (Corporate Finance) Rhys Williams (Corporate Broking / Sales)	020 7220 0500
Walbrook PR (Financial PR)	020 7933 8780
Tom Cooper / Paul Vann	0797 122 1972
	[email protected]

 

 

 

Notes to Editors:

 

Solid State plc (SOLI) is a leading value added group of companies providing specialist distribution, design-in and manufacturing services to those acquiring computing, power and communications products; and electronic and optoelectronic components; for use in harsh environments. 

 

Serving niche markets in oil & gas production, medical, construction, security, military and field maintenance, Solid State acts as both a component supplier to OEMs and bespoke manufacturer of specialist units to clients with complex requirements.

 

Headquartered in Redditch, Solid State employs over 200 staff across the UK with a sales office in the USA.  Solid State operates through two main divisions: Manufacturing and value added Distribution.

 

Solid State was established in 1971 and admitted to AIM in June 1996.

 

 

 

No statement in this announcement is intended to be a profit forecast or estimate and no statement in this announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

ACQLLFERLVLTIIT

Close

×

RNS Number : 7798G

Pennant International Group PLC

08 November 2018

 

                                                                                                                                                           

FOR IMMEDIATE RELEASE                                                                                  08 November 2018   

 

 

PENNANT INTERNATIONAL GROUP PLC

 

 

Major Contract Award valued at up to c. C$30 million

&

Contracts Update

 

 

Pennant International Group plc ("Pennant" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, is pleased to provide the following update on recent contract developments.

 

Integrated Logistics Support

 

The Canadian government has awarded a new consulting services contract to Pennant Canada Limited for the use and optimisation of Pennant's OmegaPS suite of supportability software which is used throughout the Canadian Department for National Defence ("DND"), further extending the 18-year consultancy relationship between Pennant and the DND.

 

The contract provides a framework which allows for services to be called upon on an 'as and when required basis' for an initial two-year term with the option to extend until November 2023. The initial value of the two-year framework is C$11.9 million, with the overall value (for the full five years) being in the region of C$30 million (as against C$19.7 million for the previous contract). 

 

Pennant's OmegaPS and OmegaPS Analyzer are the Logistic Support Analysis and Life Cycle Costing software products of choice for the DND and have been used extensively throughout the department since the early 1990s.

 

Philip Walker, Pennant CEO commented: "We are delighted to have secured this new contract with the Canadian DND, which is testament to the close, long-standing partnership Pennant has with the DND. The award confirms the capability and value of the OmegaPS suite and provides a firm foundation for the continued expansion of the Group's consulting business globally."

 

Technical Documentation

 

Pennant has also secured an initial order from a new customer (a prime rail car builder) for the provision of technical documentation services. The value of the order is not being disclosed but is expected to grow over time and builds on the Group's extensive experience and well-established reputation in technical documentation services in the rail sector.

 

Training Solutions

 

Furthermore, the Group has made good progress in negotiations relating to the potential contract first announced on 9 August 2018 for the design, build and delivery of training equipment to an undisclosed customer for which it has been 'down-selected'. Preliminary exchanges of data are ongoing and preparatory works are under way. It is currently anticipated that the customer will formally award the contract in either late 2018 or during the first half of 2019. The potential value of the contract (£25 million to £30 million) remains unchanged.

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Enquiries:

 

Pennant International Group plc	www.pennantplc.co.uk
Philip Walker, CEO David Clements, Commercial & Risk Director	+44 (0) 1452 714 914
WH Ireland Limited	www.whirelandcb.com
Mike Coe	+44 (0) 117 945 3470
Walbrook PR (Financial PR)	[email protected]
Paul Vann / Tom Cooper	+44 (0)20 7933 8780 +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTUWURRWKAARAA

Close

×

RNS Number : 4057G

Surgical Innovations Group PLC

06 November 2018

 

 

                                                                     Surgical Innovations Group plc                                                                    

("Surgical Innovations")

 

Surgical robot technology UK distribution deal

Elemental Healthcare signs Distribution agreement with surgical robot manufacturer DistalMotion

 

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Limited, has signed a three year exclusive UK distribution agreement with DistalMotion SA, a Swiss manufacturer of a new surgical robot.

 

The 'Dexter' robot brings a totally new dimension to the clinical efficacy of robotic surgery, allowing a surgeon to swap from robotic to laparoscopic surgery and back as required within the sterile field. 'Dexter' will be CE marked in mid-2019 giving Elemental Healthcare time to train a dedicated team in preparation for its launch.

 

Adam Power, Group Development Director of Surgical Innovations Group plc, commented: "The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate. 'Dexter' offers a much broader range of surgical opportunities and employs a novel funding model. As a consequence, we expect 'Dexter' by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals."

 

Dr Matthias Reif, Head of Sales and Marketing of DistalMotion SA commented: "Elemental Healthcare is a proven partner to commercialise innovative technology, and we are excited to partner as we believe this is the best route to commercialise 'Dexter'. The UK market is among the largest medical device markets in Europe, and a key region for Distalmotion to prove robotic surgery can be simplified and integrated into laparoscopic surgery."

 

For more information on DistalMotion SA, please visit: www.distalmotion.com

 

For further information please contact:

 

Surgical Innovations Group plc	www.sigroupplc.com
Nigel Rogers, Executive Chairman	Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)	Tel: 0207 220 1666
Adrian Hadden Chris Viggor
Walbrook PR  (Financial PR & Investor Relations)	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRABRBDBRBGBGIU

Close

×

RNS Number : 8867F

EU Supply PLC

31 October 2018

 

RNS Reach

31 October 2018

EU Supply plc

("EU Supply", the "Company" or the "Group")

 

Contract Win

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce that the States of Guernsey has entered into an agreement with the Company to license its CTMTM service platform as SaaS with support and related services. CTMTM will become the States of Guernsey's national eProcurement service.

 

The contract was awarded following a competitive tendering process with the award criteria including ease of use, breadth and depth of functionality and speed of implementation. EU Supply's CTMTM platform will go live early in 2019.

 

Thomas Beergrhen, CEO of EU Supply plc, commented: "This contract is of particular significance to the Company as it highlights demand for CTMTM, an advanced competitive tendering service platform, also from a jurisdiction outside of the EU and the European Economic Area."

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Fredrik Wallmark, CFO       Stockdale Securities Tel: 020 7601 6100 Tom Griffiths, Ed Thomas

 

A copy of this announcement is available at www.eu-supply.com.

 

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for e-sourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 8,000 European public sector bodies in 9 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013. In August and September 2015, the Company raised a total of £2.061m (before expenses) through a placing of new shares and the issue of first and second tranches of Convertible Loan Notes to institutional and other investors. On 25 May 2018, the Company announced that it had raised a further £600k (before expenses) through a placing and subscription of new shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAFFLFXVBFEFBF

Close

×

RNS Number : 7859F

Concepta PLC

31 October 2018

 

31 October 2018

Concepta Plc

("Concepta" or the "Company")

myLotus® launch: Saturday 3rd November The Fertility Show, Olympia, London

Concepta Plc (AIM: CPT), the innovative UK healthcare company and developer of the proprietary self-test platform ("myLotus® ") and suite of emerging test products targeting the mobile health market is pleased to announce the launch of its breakthrough myLotus®  product for women's fertility at the Fertility Show, Olympia, London, stand H22 over the weekend of the 3rd/4th November 2018.

myLotus® allows women to self-test to identify their optimal fertile days thereby improving their chances of naturally getting pregnant. myLotus® enables women to monitor their fertile phase as part of their menstrual cycle and is the only home test to 'quantitatively' measure personalised hormone levels and the 'rate-of-change' of these levels preceding ovulation to help aid a natural conception. Users measure, record and track their hormone levels and follow their fertility journey in an accompanying free downloadable app.  

myLotus® will be available to women who are planning to start a family or for those who have previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment.   

The Fertility Show stand will also include representation from Key Opinion Leaders, fertility doctors and health experts who will be available to discuss myLotus®.

Matthew Walls, Chairman said: "The Fertility Show marks the UK launch of our myLotus® fertility product and the start of our roll-out across CE territories. Women attending the show can exclusively buy a Starter Pack, consisting of a myLotus® monitor, 3 packs of 20 Ovulation Tests (LH) and 3 packs of 3 Pregnancy Tests (hCG), at the 'Special Launch' price of £199. We look forward to an exciting Fertility Show and to welcoming women and couples to our stand. myLotus® will also be available online at www.myLotus.com"

 

Enquiries

Company: www.conceptaplc.com, Product: www.myLotus.com

Matthew Walls, Chairman

Tel: +44 (0) 1234 866601

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin / Mark Brady

Tel: +44 (0)20 368 3550

 

Novum Securities

Colin Rowbury

+44 (0) 20 7399 9400

 

Yellow Jersey PR Limited (Financial PR)

Georgia Colkin / Joe Burgess/Katie Bairsto

Tel: +44 (0) 776 932 5254

 

About Concepta Plc:

Concepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalised mobile health market with a primary focus on increasing a woman's chances of getting pregnant naturally and for unexplained infertility in women.

myLotus® is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fertility issues. The proposition of myLotus® is to help women conceive naturally by identifying their window of fertility and optimal time for conception.

The Company has received CE-mark certification for myLotus® and is preparing its B2C launch in the UK and Europe. The Company has identified a significant global market opportunity with revenue potential of the EU and Chinese unexplained infertility market estimated to be worth c.£600m per annum.

Concepta has also made progress in establishing relationships with a number of distributors in China where myLotus® has been given cFDA approval. Concepta is initially targeting the traditional route to market in China through Chinese hospitals and plans to add the B2C route in the near future. 

myLotus® is expected to be beneficial to users diagnosed with 'unexplained infertility' who have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF typically not offered until two years. Research indicates couples start to take positive action ahead of this time with little medical support to help them do so.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCWGGCGUUPRPPU

Close

×

RNS Number : 5890F

Tracsis PLC

30 October 2018

 

30 October 2018

Tracsis plc

("Tracsis" or the "Group")

 

Significant Contract Win

 

Tracsis plc, a leading provider of software and services for the traffic data and transportation industry, is pleased to announce that it has secured a significant order for data hosting services and software licences with a major rail client.  The order is predominantly a renewal and extension of existing arrangements, over a two year period with a value in excess of £2m.

The Directors are keen to stress that this win does not change current year financial forecasts but is a further positive step forward in the Group's evolution towards delivering larger technology deals and cementing its position as a valued supplier within the UK rail industry.

 

Enquiries:

Tracsis plc                                                                                                                                             Tel: 0845 125 9162

John McArthur, CEO

Max Cawthra, CFO

finnCap Ltd                                                                                                                                           Tel: 020 7220 0500

Christopher Raggett/Scott Mathieson, Corporate Finance

Andrew Burdis, Corporate Broking

The information communicated in this announcement is inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Notes to editors: 

·   The Group specialises in solving a variety of data capture, reporting and resource optimisation problems along with the provision of a range of associated professional services.

·   Tracsis' products and services are used to increase efficiency, reduce cost and improve the operational performance and decision making capabilities for clients and customers. 

·   The Company offers the following services:

·     Rail Technology & Services: Software and technology led consulting, and remote condition monitoring: Industry strength software that covers a variety of asset classes working alongside consulting and related professional services across the operational and strategic planning horizon, plus technology and reporting for critical infrastructure assets in real time, to identify problems and aid with preventative maintenance.

·     Traffic & Data Services: Collation, analytical services, and event management within traffic and pedestrian rich environments.  The business provides technology and data that is instrumental in the development of 21st century intelligent transport systems and smart cities.

·   Tracsis has a blue chip client base which includes all major UK transport owning Groups.  The business also works extensively with Network Rail, the Department of Transport, TfL, multiple local authorities, major outdoor music and sporting events, and a wide variety of large engineering and infrastructure companies.

·   The business drives growth both organically and through acquisition and has made ten acquisitions since 2008.

·   For more information on Tracsis please visit http://www.tracsis.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTDKLFLVBFLFBK

Close